Abstract
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Issue: Nov/Dec 2007 - High-Technology Compounding
Page(s): 520-524
Abstract
Palonosetron hydrochloride is a relatively long-acting selective 5-HT3 receptor antagonist that has been approved for the prevention of chemotherapy-induced nausea and vomiting and is being evaluated for the prevention of postoperative nausea and vomiting. The objective of this study was to evaluate the physical and chemical stability of palonosetron hydrochloride 50 mcg/mL with the b-lactam antibiotics cefazolin sodium 20 mg/mL, cefotetan disodium 20 mg/mL, and the combination ampicillin sodium–sulbactam sodium 20 mg/mL and 10 mg/mL, respectively, during simulated Y-site administration. The effects of each of the antibiotics on palonosetron hydrochloride in these admixtures were tested in triplicate. Samples were stored and evaluated for up to 4 hours at room temperature. Physical stability was assessed by turbidimetric and particulate measurements and visual inspection. Chemical stability was assessed by high-performance liquid chromatography. All of the admixtures were clear and colorless when viewed in normal fluorescent room light and when viewed with a Tyndall beam. Measured turbidity and particulate content were low initially and remained low throughout the study. The drug concentration was unchanged in all of the samples tested. Palonosetron hydrochloride is physically and chemically stable in admixtures with cefazolin sodium, cefotetan disodium, and the combination ampicillin sodium–sulbactam sodium at the concentrations tested during simulated Y-site administration over 4 hours at ambient room temperature.
Related Keywords
- palonosetron hydrochloride
- antiemetic agent
- vomiting
- 5-HT3 receptor antagonist
- stability
- compatibility
- drug admixtures
- beta-lactam antibiotics
- cefazolin sodium
- ampicillin sodium sulbactam sodium
- cefotetan sodium
- parenteral administration
- infusion
Related Categories
- GASTROENTEROLOGY
- PARENTERALS
- PEER-REVIEWED
- STABILITIES, COMPATIBILITIES
- INFECTIOUS DISEASE
- NEUROLOGY
Related Articles from IJPC
Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
---|---|
Nov/Dec 2007
Pg. 520-524
|
|
Mar/Apr 2008
Pg. 156-160
|
|
Mar/Apr 2008
Pg. 170-173
|
|
Jan/Feb 2009
Pg. 78-80
|
|
Jul/Aug 2008
Pg. 368-371
|
|
Sep/Oct 2008
Pg. 460-462
|
|
Jan/Feb 2017
Pg. 76-82
|
|
May/Jun 2005
Pg. 238-241
|
Author(s):
Trissel Lawrence A, Xu Quanyun A
|
Jul/Aug 2002
Pg. 311-315
|
Author(s):
Trissel Lawrence A, Saenz Christopher
|
Jul/Aug 2016
Pg. 328-332
|
|
May/Jun 2005
Pg. 235-237
|
Author(s):
Trissel Lawrence A, Xu Quanyun A
|
Jan/Feb 2018
Pg. 76-85
|
|
May/Jun 2008
Pg. 276-278
|
|
Jan/Feb 2001
Pg. 69-73
|
|
Sep/Oct 2013
Pg. 436-438
|
|
Jan/Feb 2018
Pg. 86-94
|
|
Jan/Feb 2021
Pg. 52-61
|
Author(s):
Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
|
May/Jun 2006
Pg. 234-236
|
|
May/Jun 2006
Pg. 230-233
|
|
Jan/Feb 2007
Pg. 82-85
|
Abstract
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Issue: Nov/Dec 2007 - High-Technology Compounding
Page(s): 520-524
Abstract
Palonosetron hydrochloride is a relatively long-acting selective 5-HT3 receptor antagonist that has been approved for the prevention of chemotherapy-induced nausea and vomiting and is being evaluated for the prevention of postoperative nausea and vomiting. The objective of this study was to evaluate the physical and chemical stability of palonosetron hydrochloride 50 mcg/mL with the b-lactam antibiotics cefazolin sodium 20 mg/mL, cefotetan disodium 20 mg/mL, and the combination ampicillin sodium–sulbactam sodium 20 mg/mL and 10 mg/mL, respectively, during simulated Y-site administration. The effects of each of the antibiotics on palonosetron hydrochloride in these admixtures were tested in triplicate. Samples were stored and evaluated for up to 4 hours at room temperature. Physical stability was assessed by turbidimetric and particulate measurements and visual inspection. Chemical stability was assessed by high-performance liquid chromatography. All of the admixtures were clear and colorless when viewed in normal fluorescent room light and when viewed with a Tyndall beam. Measured turbidity and particulate content were low initially and remained low throughout the study. The drug concentration was unchanged in all of the samples tested. Palonosetron hydrochloride is physically and chemically stable in admixtures with cefazolin sodium, cefotetan disodium, and the combination ampicillin sodium–sulbactam sodium at the concentrations tested during simulated Y-site administration over 4 hours at ambient room temperature.
Related Keywords
- palonosetron hydrochloride
- antiemetic agent
- vomiting
- 5-HT3 receptor antagonist
- stability
- compatibility
- drug admixtures
- beta-lactam antibiotics
- cefazolin sodium
- ampicillin sodium sulbactam sodium
- cefotetan sodium
- parenteral administration
- infusion
Related Categories
- GASTROENTEROLOGY
- PARENTERALS
- PEER-REVIEWED
- STABILITIES, COMPATIBILITIES
- INFECTIOUS DISEASE
- NEUROLOGY
Related Articles from IJPC
Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
---|---|
Nov/Dec 2007
Pg. 520-524
|
|
Mar/Apr 2008
Pg. 156-160
|
|
Mar/Apr 2008
Pg. 170-173
|
|
Jan/Feb 2009
Pg. 78-80
|
|
Jul/Aug 2008
Pg. 368-371
|
|
Sep/Oct 2008
Pg. 460-462
|
|
Jan/Feb 2017
Pg. 76-82
|
|
May/Jun 2005
Pg. 238-241
|
Author(s):
Trissel Lawrence A, Xu Quanyun A
|
Jul/Aug 2002
Pg. 311-315
|
Author(s):
Trissel Lawrence A, Saenz Christopher
|
Jul/Aug 2016
Pg. 328-332
|
|
May/Jun 2005
Pg. 235-237
|
Author(s):
Trissel Lawrence A, Xu Quanyun A
|
Jan/Feb 2018
Pg. 76-85
|
|
May/Jun 2008
Pg. 276-278
|
|
Jan/Feb 2001
Pg. 69-73
|
|
Sep/Oct 2013
Pg. 436-438
|
|
Jan/Feb 2018
Pg. 86-94
|
|
Jan/Feb 2021
Pg. 52-61
|
Author(s):
Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
|
May/Jun 2006
Pg. 234-236
|
|
May/Jun 2006
Pg. 230-233
|
|
Jan/Feb 2007
Pg. 82-85
|